Back to 
Avoro Capital Advisors LLC
Avoro Capital Advisors LLC
CUE
Showing 0 of 6 quarters
Position history for Avoro Capital Advisors LLC's holdings in CUE BIOPHARMA INC
No. Avoro Capital Advisors exited its CUE (Cue Biopharma) position in Q1 2021. Its Q4 2020 13F listed 452,500 shares worth $5.7M. Avoro Capital Advisors first reported CUE in Q4 2019 and held it in 5 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.